Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients
Authors
Keywords
-
Journal
CELL CYCLE
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2018-09-08
DOI
10.1080/15384101.2018.1520558
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer
- (2017) Manmei Long et al. Molecular Cancer
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Multiple regulatory mechanisms of the biological function of NRF3 (NFE2L3) control cancer cell proliferation
- (2017) A. M. Masudul Azad Chowdhury et al. Scientific Reports
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Suppression of KSHV-induced angiopoietin-2 inhibits angiogenesis, infiltration of inflammatory cells, and tumor growth
- (2016) Xiaolan Yu et al. CELL CYCLE
- Hypoxia-induced DNp73 stabilization regulates Vegf-A expression and tumor angiogenesis similar to TAp73
- (2015) Iqbal Dulloo et al. CELL CYCLE
- VEGF and dual-EGFR inhibition in colorectal cancer
- (2015) Gerald S Falchook et al. CELL CYCLE
- Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3)
- (2015) Meenakshi B. Kannan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Approach to Patients With Pancreatic Cancer Without Detectable Metastases
- (2015) Gregory M. Heestand et al. JOURNAL OF CLINICAL ONCOLOGY
- A step closer to screening for curable pancreatic cancer?
- (2015) Marcia I. Canto et al. Nature Reviews Gastroenterology & Hepatology
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nrf3-Pla2g7 Interaction Plays an Essential Role in Smooth Muscle Differentiation From Stem Cells
- (2012) Qingzhong Xiao et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- NFE2L3 (NRF3): the Cinderella of the Cap‘n’Collar transcription factors
- (2011) Grégory Chevillard et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Nfe2l3 (Nrf3) deficiency predisposes mice to T-cell lymphoblastic lymphoma
- (2010) G. Chevillard et al. BLOOD
- Nrf2: A central regulator of UV protection in the epidermis
- (2010) Matthias Schafer et al. CELL CYCLE
- Crucial Role of Nrf3 in Smooth Muscle Cell Differentiation From Stem Cells
- (2010) Anna Elena Pepe et al. CIRCULATION RESEARCH
- Molecular biology of mantle cell lymphoma: From profiling studies to new therapeutic strategies
- (2009) Antònia Obrador-Hevia et al. BLOOD REVIEWS
- Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease?
- (2008) Helga E. de Vries et al. FREE RADICAL BIOLOGY AND MEDICINE
- Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model
- (2008) Dong Keun Rhee et al. GENOMICS
- The Nrf3 Transcription Factor Is a Membrane-bound Glycoprotein Targeted to the Endoplasmic Reticulum through Its N-terminal Homology Box 1 Sequence
- (2008) Yiguo Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started